rickettsi
pathogen
among
lead
caus
morbid
mortal
militari
oper
recent
year
emerg
rickettsi
diseas
report
throughout
world
signific
medic
concern
local
deploy
personnel
travel
pathogen
includ
spot
fever
group
rickettsia
sfgr
far
eastern
spot
fever
japanes
spot
fever
siberian
queensland
tick
typhu
thai
tick
typhu
name
typhu
group
rickettsia
tgr
epidem
murin
typhu
orientia
tsutsugamushi
scrub
typhu
st
due
high
mortal
rate
untreat
rickettsi
infect
earli
treatment
appropri
antibiot
critic
doxycyclin
drug
choic
except
case
pregnanc
tetracyclin
hypersensit
symptom
rickettsi
infect
nonspecif
confus
varieti
pathogen
eg
dengu
malaria
leptospirosi
requir
differ
treatment
regimen
ensur
appropri
treatment
initi
promptli
earli
diagnosi
rickettsi
infect
critic
current
diagnosi
rickettsi
diseas
reli
mainli
serolog
method
base
antibodi
detect
howev
antibodi
base
assay
may
adequ
diagnosi
diseas
acut
phase
antibodi
level
may
detect
onset
ill
therefor
antigenpathogen
detect
rise
antibodi
level
import
almost
antigenpathogen
detect
assay
rickettsi
diseas
base
polymeras
chain
reaction
pcr
quantit
realtim
pcr
qpcr
nest
pcr
target
differ
gene
includ
kda
groel
tsutsugamushi
ompb
kda
glta
rickettsia
howev
assay
requir
end
user
train
oper
thermocycl
function
wellcalibr
thermocycl
difficult
obtain
maintain
resourc
poor
set
recent
loopmedi
isotherm
amplif
develop
potenti
altern
pcr
base
test
addit
groel
target
huber
et
al
demonstr
use
conserv
kda
gene
target
lamp
assay
achiev
similar
sensit
qpcr
recombinas
polymeras
amplif
rpa
use
mixtur
prokaryot
recombinas
guid
synthet
oligonucleotid
primer
target
sampl
wwwtwistdxcouk
detail
descript
strand
displac
dna
polymeras
larg
fragment
bacillu
subtili
pol
bsu
use
primer
extens
method
highli
sequenc
specif
complex
nucleic
acid
mixtur
urin
without
need
addit
prepar
sampl
offer
amplif
target
sequenc
reiter
oligonucleotideprim
dna
synthesi
without
need
denatur
dna
high
temperatur
assay
perform
high
effici
detect
product
singl
molecul
possibl
minut
success
applic
rpa
evid
shown
mani
recent
public
rtrpa
develop
detect
hiv
rift
valley
fever
viru
ebola
viru
sudan
viru
marburg
viru
merscov
footandmouth
diseas
viru
bovin
coronaviru
addit
assay
develop
detect
chlamydia
trachomati
urin
sampl
diagnosi
cryptosporidiosi
anim
patient
specimen
detect
neisseria
gonorrhoea
salmonella
enterica
methicillinresist
staphylococcu
aureu
mrsa
francisella
tularensi
group
b
streptococci
furthermor
assay
use
combin
elisa
food
analysi
rpa
similar
lamp
thermocycl
need
optim
reaction
temperatur
rpa
lamp
respect
addit
rpa
potenti
easier
adapt
multiplex
format
lamp
rpa
requir
one
pair
primer
rather
three
like
lamp
mix
multipl
pair
primer
may
result
nonspecif
primer
interact
may
limit
total
amount
primer
abl
ad
reaction
final
incorpor
probe
increas
specif
assay
particularli
import
lamp
assay
known
result
nonspecif
amplif
advantag
suggest
rpa
may
viabl
pointofcar
nucleic
acid
detect
method
util
resourceslimit
area
diseas
endem
report
demonstr
later
flow
end
point
detect
rpa
twistampnfo
kit
hereaft
rpanfo
could
perform
minut
detect
dna
either
tsutsugamushi
r
typhi
similarli
realtim
fluoresc
signal
detect
twistampexo
kit
hereaft
rpaexo
could
perform
detect
dna
either
tsutsugamushi
r
typhi
detect
limit
similar
gold
standard
qpcr
achiev
rpaexo
rpanfo
specif
evalu
use
genom
dna
close
relat
microorgan
fold
excess
copi
number
detect
limit
establish
use
rang
target
genom
dna
high
copi
per
reaction
less
copi
per
reaction
evalu
done
use
dna
extract
liver
lung
spleen
collect
tsutsugamushi
infect
mice
dna
extract
clinic
sampl
obtain
confirm
st
patient
sera
r
typhispik
normal
human
plasma
cross
contamin
proof
xcp
later
flow
cassett
use
detect
rpanfo
amplicon
method
elimin
need
open
reaction
tube
end
reaction
thu
minim
chanc
contamin
anim
studi
protocol
review
approv
naval
medic
research
center
institut
anim
care
use
committe
iacuc
complianc
applic
feder
regul
govern
protect
anim
research
experi
report
herein
conduct
complianc
anim
welfar
act
accord
principl
set
forth
guid
care
use
laboratori
anim
institut
laboratori
anim
resourc
nation
research
council
nation
academi
press
oligonucleotid
primer
use
rpa
assay
manual
design
base
kda
gene
sequenc
karp
strain
tsutsugamushi
kda
gene
sequenc
wilmington
strain
r
typhi
per
recommend
twistdx
cambridg
uk
minimum
set
primer
probe
target
design
differ
endpoint
detect
method
primer
probe
synthes
eurofin
mwg
operon
huntsvil
al
biosearch
technolog
petaluma
ca
respect
probe
hplc
purifi
rpanfo
rpaexo
kit
purchas
twistdx
cambridg
uk
wwwtwistdxcouk
amplicon
gener
rpanfo
detect
use
later
flow
strip
cassett
fig
rpaexo
use
monitor
fluoresc
signal
real
time
use
fluorimet
fig
fig
show
gener
scheme
describ
design
experi
pcr
product
kda
gene
sequenc
otsutsugamushi
karp
strain
kda
gene
r
typhi
wilmington
strain
clone
vector
puc
vector
respect
follow
standard
molecular
biolog
technolog
plasmid
extract
ml
cultur
use
qiagen
plasmid
mini
kit
qiagen
ca
follow
manufactur
instruct
concentr
determin
use
nanodrop
thermo
fisher
scientif
ca
expect
copi
number
target
gene
calcul
base
size
plasmid
http
celsuriedugsccndnahtml
purifi
plasmid
use
templat
optim
rpa
assay
genom
dna
multipl
strain
tsutsugamushi
includ
karp
garton
ikeda
boryong
tgr
sfgr
extract
renografin
gradient
purifi
organ
use
qiaamp
mini
dna
kit
qiagen
ca
previous
describ
similarli
dna
cultur
leptospira
coxiella
burnetii
bartonella
bacillifomi
extract
method
dna
extract
blood
patient
confirm
st
provid
us
dr
yupin
suputtamongkol
siriraj
hospit
mahidol
univers
bangkok
thailand
anim
protocol
perform
mous
experi
approv
nmrc
iacuc
accord
approv
protocol
mice
challeng
intraperiton
ip
karp
strain
tsutsugamushi
observ
day
indic
time
post
infect
mice
sacrif
variou
organ
collect
includ
lung
liver
spleen
genom
dna
extract
organ
follow
manufactur
instruct
qiaamp
blood
tissu
mini
dna
kit
qiagen
ca
prepar
cultur
r
typhispik
nhp
number
r
typhi
present
three
independ
prepar
r
typhi
cultur
determin
dna
extract
three
r
typhi
cultur
use
qiaamp
blood
tissu
dna
kit
follow
manufactur
instruct
bacteri
load
determin
qpcr
within
rang
initi
dilut
made
ad
cultur
r
typhi
nhp
dilut
follow
serial
dilut
use
nhp
diluent
ensur
final
concentr
spike
nhp
copiesml
cultur
r
typhi
dna
r
typhispik
nhp
extract
use
qiaamp
blood
tissu
dna
kit
dna
use
templat
assay
evalu
perform
qpcr
use
quantit
copi
number
kda
gene
forward
primer
mix
differ
revers
primer
separ
examin
pair
perform
best
use
plasmid
dna
copi
templat
differ
reaction
time
concentr
primer
probe
temperatur
rang
evalu
select
sensit
combin
rpa
reaction
per
manufactur
recommend
twistdx
cambridg
uk
combin
paramet
perform
least
twice
temperatur
rang
vari
everi
degre
within
rang
recommend
manufactur
evalu
done
use
rpanfo
rpa
reaction
result
evalu
use
milenia
genlin
mgh
strip
millenia
biotec
gmbh
gieben
germani
base
evalu
perform
previou
section
final
condit
carri
recombinas
polymeras
amplif
describ
reaction
mixtur
use
rpaexo
rpanfo
reaction
mixtur
contain
rehydr
buffer
recombinas
bsu
strand
displac
polymeras
addit
nm
forward
revers
primer
nm
famtag
probe
total
volum
mix
compon
mm
magnesium
acet
pipet
tube
lid
dna
ad
reaction
mixtur
unless
otherwis
indic
lid
close
magnesium
acet
spun
reaction
mixtur
initi
reaction
rpaexo
tube
place
esequ
tube
scanner
devic
qiagen
ca
reaction
conduct
minut
tube
briefli
agit
minut
initi
reaction
spun
place
back
tube
scanner
reaction
tube
monitor
real
time
follow
increas
fluoresc
signal
rpanfo
tube
place
heat
block
minut
tube
briefli
agit
minut
reaction
initi
spun
place
back
heat
block
mgh
strip
use
evalu
result
accord
manufactur
instruct
reaction
complet
reaction
sampl
amplicon
use
strip
develop
altern
detect
method
reaction
complet
entir
reaction
tube
insert
xcp
cassett
bioustar
hongzhou
china
cassett
close
per
manufactur
instruct
presenc
signal
line
indic
posit
detect
dna
use
fam
label
probe
copi
number
genom
dna
extract
previous
describ
determin
qpcr
dna
dilut
desir
copi
number
total
volum
perform
rpa
describ
previous
reaction
perform
minimum
time
amount
genom
dna
due
limit
avail
extract
dna
scrub
typhu
confirm
patient
perform
dna
dna
tsutsugamushiinfect
mice
dna
extract
liver
spleen
lung
mice
describ
previous
evalu
perform
describ
use
extract
dna
quantit
pcr
perform
compar
confirm
detect
limit
rpa
assay
whenev
copi
number
sampl
provid
obtain
via
qpcr
use
standard
curv
built
plasmid
known
copi
number
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
use
perform
qpcr
reaction
analyz
result
primer
use
previous
use
amplifi
gene
sequenc
karp
strain
orientia
kda
gene
sequenc
r
typhi
total
reaction
mixtur
contain
forward
primer
revers
primer
target
gene
orientia
kda
gene
r
typhi
sybr
green
qpcr
mastermix
sabiosci
frederick
md
dna
templat
initi
activ
step
follow
cycl
second
second
melt
curv
determin
cycl
determin
amount
mous
genom
dna
total
dna
extract
organ
tsutsugamushi
infect
mice
qpcr
perform
describ
sunyakumthorn
et
al
run
rpanfo
reaction
differ
primer
probe
combin
incub
temperatur
reaction
time
mention
materi
method
appli
sever
perform
factor
includ
total
signal
strength
absenc
background
signal
mgh
strip
detect
limit
determin
combin
primer
probe
includ
concentr
reaction
temperatur
reaction
time
provid
lowest
limit
detect
use
qpcr
gold
standard
quantit
dna
establish
detect
limit
primer
probe
set
provid
best
detect
limit
individu
detect
tsutsugamushi
r
typhi
dna
identifi
tabl
fig
show
typic
result
detect
differ
copi
number
kda
gene
appear
detect
copiesreact
slightli
higher
qpcr
copiesreact
differ
strain
isol
tsutsugamushi
includ
karp
kato
gilliam
ikeda
garton
boryong
test
region
bp
kda
sequenc
rpa
primer
target
share
greater
homolog
among
strain
fig
detect
limit
rang
copi
per
reaction
similarli
detect
r
typhi
dna
use
differ
copi
number
kda
gene
repres
shown
fig
abl
detect
around
copi
per
reaction
slightli
higher
qpcr
copi
per
reaction
result
shown
fig
indic
level
detect
around
copi
per
reaction
similar
qpcr
copi
per
reaction
respect
similarli
show
level
detect
copi
per
reaction
fig
compar
qpcr
copi
copi
per
reaction
respect
furthermor
signific
rise
fluoresc
signal
time
ie
slope
observ
later
minut
post
initi
reaction
even
though
signal
plateau
within
minut
suggest
possibl
differenti
posit
neg
sampl
base
slope
reflect
chang
fluoresc
signal
time
evalu
whether
detect
tsutsugamushi
r
typhi
respect
purifi
genom
dna
phylogenet
relat
organ
test
dna
r
typhi
r
bellii
r
rickettsii
r
conorii
leptospira
c
burnetii
b
bacilliformi
use
none
posit
fig
consist
observ
show
reactiv
dna
tsutsugamushi
leptospira
c
burnetii
b
bacilliformi
fig
result
obtain
use
note
use
detect
r
conorii
r
rickettsii
posit
result
observ
least
copiesreact
dna
present
fig
suggest
assay
much
less
sensit
detect
two
sfgr
sfgr
r
honei
r
japonica
also
evalu
show
detect
unless
copi
dna
present
result
obtain
use
addit
perform
also
evalu
use
dna
extract
r
prowazekii
assay
consist
detect
low
copi
per
reaction
taken
togeth
result
consist
notion
better
suit
detect
tgr
differ
amount
extract
genom
dna
use
evalu
detect
limit
two
rpa
method
run
least
replic
assay
differ
detect
limit
wherea
similar
detect
limit
shown
tabl
test
assay
detect
sampl
copi
copi
copi
per
reaction
respect
use
assay
posit
sampl
copi
copi
copi
copi
per
reaction
respect
base
result
significantli
lower
detect
limit
rpaexo
detect
sampl
rang
copi
copi
copi
per
reaction
respect
hand
detect
sampl
rang
copi
copi
copi
copi
per
reaction
respect
statist
signific
differ
tabl
fisher
exact
test
percentag
posit
sampl
detect
variou
rang
use
suggest
detect
limit
compar
evalu
use
total
posit
neg
human
sampl
result
show
posit
posit
neg
neg
fig
similar
observ
use
lamp
method
even
though
ran
use
instead
dna
due
limit
avail
extract
dna
nevertheless
limit
number
clinic
confirm
st
patient
show
exhibit
sensit
specif
also
evalu
use
extract
dna
liver
spleen
lung
laboratori
tsutsugamushiinfect
mice
sampl
confirm
qpcr
neg
day
post
infect
gradual
increas
quantiti
seen
shown
tabl
extract
dna
use
templat
among
sampl
qpcr
neg
sampl
determin
neg
among
qpcr
posit
sampl
detect
posit
result
demonstr
sensit
specif
achiev
use
dna
extract
organ
obtain
tsutsugamushiinfect
mice
taken
togeth
conclud
provid
around
sensit
specif
due
lack
qpcr
confirm
rtyphi
posit
patient
sampl
clinic
perform
evalu
spike
normal
human
plasma
cultur
r
typhi
result
qpcr
quantit
shown
tabl
qpcr
posit
sampl
posit
base
amount
r
typhi
dna
spike
nhp
final
copi
r
typhi
extract
dna
dna
extract
result
averag
dna
recoveri
use
xcp
cassett
replac
mgh
strip
end
rpanfo
reaction
fam
label
probe
show
signal
line
fig
like
strip
result
demonstr
potenti
usag
xcp
cassett
replac
mgh
strip
detect
rpanfo
amplicon
xcp
cassett
requir
open
reaction
tube
use
reaction
volum
detect
conceiv
usag
xcp
cassett
detect
end
product
could
sensit
present
less
opportun
contamin
usag
mgh
strip
detect
rpanfo
product
data
present
show
rpa
method
could
use
detect
plasmid
dna
dna
extract
patient
sampl
infect
mice
pure
organ
detect
limit
ten
copi
within
minut
gener
compar
qpcr
fig
tabl
detect
limit
observ
like
due
limit
rpa
assay
shown
detect
product
amplifi
singl
molecul
rather
conceiv
detect
limit
improv
differ
gene
select
assay
develop
addit
similar
detect
limit
rpa
method
sever
advantag
qpcr
make
attract
altern
firstli
heat
block
capabl
maintain
temperatur
minut
suffici
perform
reaction
secondli
reaction
mixtur
premad
provid
twistdx
addit
water
templat
primer
probe
reaction
initi
upon
mix
thu
minim
potenti
contamin
often
observ
nucleic
acid
amplif
method
thirdli
method
offer
multipl
endpoint
detect
option
similar
detect
limit
could
fit
mani
differ
laboratori
set
thu
make
one
assay
applic
wellequip
laboratori
mobil
laboratori
rural
area
instrument
infrastructur
may
limit
final
success
detect
tsutsugamushi
clinic
mous
sampl
known
infect
demonstr
potenti
clinic
applic
assay
rpa
method
develop
almost
year
ago
howev
accept
well
isotherm
amplif
method
ie
lamp
although
method
rel
easi
perform
advantag
describ
previous
one
difficulti
lie
design
primer
probe
softwar
avail
assist
properli
design
primer
probe
set
furthermor
requir
extra
length
primer
probe
made
manual
design
difficult
method
qpcr
pcr
lamp
well
establish
softwar
primer
probe
design
rel
rare
modif
probe
also
add
cost
synthesi
consequ
may
prevent
evalu
larg
number
potenti
primer
probe
lead
sensit
specif
assay
possibl
nevertheless
advantag
seem
outweigh
minor
drawback
mani
other
abl
demonstr
util
assay
detect
close
relat
pathogen
without
sacrif
sensit
specif
addit
develop
rpa
detect
tsutsugamushi
r
typhi
rpanfo
method
develop
c
burnetii
dna
detect
limit
assay
compar
qpcr
detect
tsutsugamushi
use
rpa
method
appear
slight
differ
detect
limit
rpanfo
copi
per
reaction
rpaexo
copi
per
reaction
contrari
differ
detect
limit
less
pronounc
r
typhi
detect
shown
tabl
due
observ
rpanfo
requir
higher
copi
target
gene
posit
detect
gener
rpanfo
assay
target
evalu
use
higher
copiesreact
addit
rang
copiesreact
best
estim
detect
limit
rpanfo
assay
test
result
use
vari
rang
genom
dna
differ
percent
posit
detect
test
rang
assay
provid
around
posit
regardless
whether
rpanfo
rpaexo
addit
result
consist
notion
later
flow
strip
gener
regard
notassensit
detect
method
fluoresc
signal
detect
use
strip
evalu
result
rpanfo
requir
reaction
tube
open
remov
sampl
reaction
complet
thu
ad
extra
post
reaction
time
increas
possibl
cross
contamin
due
presenc
abund
amplicon
cassett
form
later
flow
strip
essenti
elimin
cross
contamin
yet
still
requir
addit
time
obtain
final
result
worth
note
mgh
strip
xcp
cassett
commerci
avail
use
without
attempt
optim
perform
thu
conceiv
optim
devic
could
improv
sensit
elimin
differ
sensit
target
gene
kda
kda
select
tsutsugamushi
r
typhi
dna
detect
respect
base
rel
conserv
natur
sequenc
kda
gene
code
one
major
protein
antigen
recogn
sera
patient
infect
mani
strain
tsutsugamushi
sequenc
kda
protein
compar
show
greater
ident
strain
except
one
recent
identifi
strain
chuto
share
ident
gene
use
target
develop
pcr
qpcr
lamp
assay
shown
consist
result
sensit
specif
broad
reactiv
toward
mani
differ
strain
tsutsugamushi
region
bp
kda
rpa
target
share
greater
homolog
among
strain
test
fig
note
differ
detect
limit
observ
strain
spite
differ
detect
limit
observ
differ
strain
detect
limit
still
fall
within
broad
expect
level
otsutsugamushi
circul
patient
blood
sinc
level
tsutsugamushi
present
patient
blood
also
associ
diseas
sever
like
current
need
improv
achiev
lower
detect
limit
order
clinic
applic
similarli
kda
gene
use
confirm
presenc
rickettsia
dna
potenti
infect
sampl
addit
target
use
delin
whether
infect
due
tgr
sfgr
note
design
primer
probe
locat
latter
half
kda
sequenc
show
lower
detect
limit
r
typhi
dna
requir
copi
number
greater
r
conorii
r
rickettsii
dna
detect
fig
observ
made
r
honei
r
japonica
kda
gene
sfgr
test
share
ident
full
length
kda
gene
r
typhi
kda
gene
r
typhi
share
ident
kda
gene
r
prowazekii
anoth
member
tgr
kda
gene
r
conorii
r
rickettsia
r
honei
r
japonica
show
ident
r
typhi
within
region
primer
probe
locat
bp
ident
r
typhi
r
prowazekii
sinc
sensit
clearli
differ
r
typhi
two
speci
sfg
rickettsia
use
one
set
primer
probe
suggest
ident
enough
use
one
set
primer
probe
detect
tg
sfg
rickettsia
equal
sensit
therefor
anoth
set
primer
probe
need
sfgr
order
similar
detect
limit
r
typhi
differ
reactiv
toward
tgr
sfgr
suggest
assay
highli
specif
detect
limit
use
nhp
spike
cultur
r
typhi
copiesml
tabl
higher
median
dna
copiesml
blood
confirm
murin
typhu
patient
suggest
assay
may
sensit
enough
clinic
use
sinc
evalu
done
use
clinic
sampl
warrant
addit
evalu
done
character
clinic
sensit
specif
rpaexo
rpanfo
kit
specif
target
organ
demonstr
fig
tabl
fig
shown
amplicon
unless
target
dna
ie
tsutsugamushi
r
typhi
present
even
though
nontarget
dna
present
fold
excess
compar
target
gene
presenc
excess
human
dna
mous
dna
appar
interfer
detect
target
gene
suggest
assay
provid
suffici
specif
clinic
relev
sampl
support
result
show
pcr
confirm
tsutsugamushi
posit
posit
pcr
confirm
tsutsugamushi
neg
neg
achiev
sensit
specif
use
limit
number
clinic
sampl
also
evalu
specif
sensit
close
use
sampl
mice
infect
live
tsutsugamushi
shown
tabl
sampl
collect
prior
day
four
post
infect
qpcr
detect
tsutsugamushi
expect
due
similar
sensit
qpcr
rpa
none
sampl
posit
either
contrari
infect
progress
tsutsugamushi
dna
becam
detect
qpcr
earli
day
four
post
infect
organ
evalu
even
though
number
tsutsugamushi
detect
low
sampl
low
copi
tsutsugamushi
dna
qpcr
detect
overal
show
consist
result
sensit
specif
similar
observ
made
use
dna
extract
scrub
typhu
patient
note
number
tsutsugamushi
undetect
day
post
infect
number
low
day
post
infect
probabl
relat
number
live
organ
inject
mice
naturallyslow
growth
tsutsugamushi
rout
rate
dissemin
tsutsugamushi
enter
mice
amount
mous
dna
sampl
normal
copi
number
tsutsugamushi
mous
complement
factor
gene
cfd
ratio
mous
dna
tsutsugamushi
dna
rang
low
lung
day
high
lung
day
result
suggest
ratio
nontarget
dna
target
dna
affect
detect
target
dna
dynam
rang
either
potenti
applic
clinic
sampl
diagnosi
infect
nevertheless
number
sampl
evalu
report
limit
evalu
addit
clinic
sampl
need
better
describ
clinic
sensit
specif
work
took
advantag
similar
lamp
rpanfo
detect
fam
label
amplicon
provid
revers
primer
label
biotin
bioustar
xcp
cassett
design
specif
detect
lamp
amplicon
fam
label
loop
primer
along
biotin
label
revers
primer
use
togeth
reaction
origin
design
cline
signal
indic
intern
control
contain
dig
label
loop
primer
tline
signal
indic
posit
sampl
contain
fam
label
loop
primer
wwwbioustarcom
result
fig
clearli
demonstr
assay
posit
line
correspondingli
label
probe
present
togeth
primer
dna
templat
true
xcp
cassett
design
detect
rpanfo
product
approach
confirm
possibl
use
xcp
cassett
rpanfo
provid
end
point
readout
cross
contamin
furthermor
provid
singl
xcp
cassett
use
detect
practic
fam
dig
label
probe
amplicon
includ
qpcr
lamp
rpanfo
pickandchoos
manner
select
assay
target
organ
relev
local
area
assay
perform
conclus
work
present
demonstr
develop
rpanfo
rpaexo
detect
tsutsugamushi
r
typhi
dna
assay
detect
limit
similar
qpcr
specif
assay
evalu
use
excess
amount
mous
dna
affect
reaction
assay
also
evalu
use
extract
dna
human
patient
sampl
demonstr
around
sensit
specif
use
limit
clinic
sampl
final
eas
crosscontaminationproof
later
flow
cassett
use
detect
multipl
amplicon
variou
nucleic
acid
amplif
method
make
promis
widerang
use
field
